Project Grant R01AI189834
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a $103,256 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective December 1, 2025, with completion anticipated by June 30, 2030. The grant supports dynamic and functional analysis of Enterococcus faecalis penicillin binding protein 4 (PBP4) pedestal domain to elucidate mechanisms underlying intrinsic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $109,476 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin-Madison on November 30, 2025, with completion scheduled for May 31, 2027. This research project focuses on understanding the molecular mechanisms underlying multidrug efflux transporter function in bacteria, specifically investigating how the NorA transporter exports...
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a Project Grant award of $762,983.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025 through August 31, 2026. The award supports discovery and development of novel Human Cytomegalovirus (HCMV) inhibitors targeting the helicase-primase complex as a new antiviral mechanism. Research deliverables...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a $392,634 Project Grant effective May 13, 2025, through April 30, 2030, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds the development of a novel nanoimmunotherapeutic treatment approach targeting multidrug-resistant (MDR) bacterial infections, specifically gram-negative ESKAPE pathogens including...
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a Project Grant award of $506,105 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award supports fundamental research on the functional dynamics of essential bacterial proteins and the development of transformative electron paramagnetic resonance (EPR) spectroscopy...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $147,486 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 30, 2025, with a completion date of March 31, 2028. The grant funds research directed by investigators at the Medical College of Wisconsin in Wauwatosa, Wisconsin to uncover the proviral mechanisms by which murine...
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a $429,000 Project Grant awarded on July 17, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research project, which will be conducted in Wauwatosa, Wisconsin through June 30, 2027, focuses on investigating the effect of Borrelia burgdorferi-SIRPalpha interaction on the immune response to Lyme disease. The...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $429,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 25, 2025, with completion targeted for May 31, 2027. This research grant funds a two-part investigation into chromatin structure and gene regulation in Anopheles coluzzii mosquitoes, a principal malaria vector species. The...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a Project Grant totaling $753,899 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026, through January 31, 2031. This five-year research project will investigate the mechanisms by which butyrate, a microbiome-derived metabolite influenced by dietary fiber intake, impacts Clostridioides difficile (CD)...
- Grant Award Summary The Medical College of Wisconsin, Inc. received a Project Grant award of $225,624.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 12, 2025 through November 30, 2027. This award supports a multi-disciplinary research initiative examining the role of PagC protein in bacterial outer membrane vesicle (OMV) biogenesis in Salmonella enterica subspecies Typhymurium....
The Medical College of Wisconsin, Inc. received a $649,014 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 5, 2026, with a completion date of January 31, 2031. This research project addresses antimicrobial resistance in enterococci by investigating the conformation and functional dynamics of Class B penicillin-binding proteins (PBPs). The research will determine the conformational dynamics and in vivo function of pedestal domains across the three enterococcal Class B PBPs and examine how these domains interact with regulatory factors to confer cephalosporin resistance in hospital-acquired pathogens. The grant supports fundamental scientific research aimed at identifying new antimicrobial targets and strategies to combat antibiotic-resistant enterococci, which are significant causes of hospital-acquired infections. Through structural and functional studies of PBP pedestal domains—particularly examining their conformational changes between "closed" and "open" states—the research will advance understanding of the genetic and biochemical mechanisms underlying cephalosporin resistance. This knowledge gap addresses a critical public health challenge and contributes to the NIAID program's mission of advancing scientific understanding of infectious disease mechanisms to improve therapeutic interventions and health outcomes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $649.0k | 2/5/26 |